Taming interleukin-12: Engineering of bispecific antibody-based IL-12 mimetics with biased agonism capacities

被引:0
作者
Lipinski, Britta [1 ,2 ]
Unmuth, Laura [1 ,2 ]
Arras, Paul [1 ]
Endruszeit, Ron [1 ]
Becker, Stefan [2 ]
Roedel, Jonathan Mathias [3 ,4 ]
Scheller, Juergen [3 ,4 ]
Pudewell, Silke [3 ,4 ]
Floss, Doreen M. [3 ,4 ]
Krah, Simon [2 ]
Harwardt, Julia [2 ]
Doerner, Achim [2 ]
Helming, Laura [5 ]
Xu, Chunxiao [5 ]
Menrad, Andreas [2 ]
Evers, Andreas [2 ]
Kolmar, Harald [6 ]
Elter, Desislava [2 ]
Pekar, Lukas [2 ]
Zielonka, Stefan [1 ,2 ]
机构
[1] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Biomol Immunotherapy, Peter Grunberg Str 4, D-64287 Darmstadt, Germany
[2] Merck Healthcare KGaA, Antibody Discovery & Prot Engn, Darmstadt, Germany
[3] Heinrich Heine Univ Dusseldorf, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany
[4] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dusseldorf, Germany
[5] EMD Serono Res Ctr, Res Unit Oncol, Billerica, MA USA
[6] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Appl Biochem, Darmstadt, Germany
关键词
antibody engineering; bispecific antibody; cytokine mimetic; IL-12; NK cell; single-domain antibody; surrogate cytokine; T cell; VHH; yeast surface display; SINGLE-DOMAIN ANTIBODIES; EXPRESSION; CYTOKINE; DELIVERY; CELL; PURIFICATION; MURINE; IL-23; NK;
D O I
10.1002/pro.70072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we have generated bispecific interleukin (IL)-12 surrogate agonists based on camelid-derived single-domain antibodies (sdAbs) targeting the IL-12 receptor (IL-12R) subunits IL-12R beta 1 and IL-12R beta 2. Following immunization and antibody display-based paratope isolation, respective sdAbs were combinatorially reformatted into a monovalent bispecific architecture by grafting resulting paratopes onto the hinge region of a heterodimeric Fc region. Functional characterization using NK-92 cells enabled the identification of multiple different sdAb-based bispecifics displaying divergent IL-12R agonism capacities as analyzed by STAT4 phosphorylation. Further investigations by harnessing peripheral blood mononuclear cells (PBMCs) from healthy donors revealed attenuated pSTAT4 activation compared to recombinant human (rh) wild-type IL-12 regarding both natural killer (NK)-cell and T-cell activation but robust IL-12R agonism on stimulated T cells. While several sdAb-based IL-12 mimetics were nearly inactive on NK cells as well as T cells obtained from PBMCs, they elicited significant STAT4 phosphorylation and interferon (IFN)-gamma release on stimulated T cells as well as an IL-12-like transcriptional signature. Furthermore, we demonstrate that the activity of receptor agonism of generated bispecific IL-12 mimetics can also be biased towards stimulated T cells by changing the spatial orientation of the individual sdAbs within the molecular design architecture. Taken together, we present an alternative strategy to generate IL-12-like biologics with tailor-made characteristics.
引用
收藏
页数:18
相关论文
共 50 条
[1]   Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells [J].
Airoldi, I ;
Gri, G ;
Marshall, JD ;
Corcione, A ;
Facchetti, P ;
Guglielmino, R ;
Trinchieri, G ;
Pistoia, V .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6880-6888
[2]   LAG-3 and PD-1 synergize on CD8+T cells to drive T cell exhaustion and hinder autocrine IFN-y-dependent anti-tumor immunity [J].
Andrews, Lawrence P. ;
Butler, Samuel C. ;
Cui, Jian ;
Cillo, Anthony R. ;
Cardello, Carly ;
Liu, Chang ;
Brunazzi, Erin A. ;
Baessler, Andrew ;
Xie, Bingxian ;
Kunning, Sheryl R. ;
Ngiow, Shin Foong ;
Manne, Sasikanth ;
Huang, Yinghui Jane ;
Sharpe, Arlene H. ;
Delgoffe, Greg M. ;
Wherry, E. John ;
Kirkwood, John M. ;
Bruno, Tulia C. ;
Workman, Creg J. ;
Vignali, Dario A. A. .
CELL, 2024, 187 (16) :4355-4372.e22
[3]  
Bauer Christina, 2023, Methods Mol Biol, V2681, P47, DOI 10.1007/978-1-0716-3279-6_4
[4]   Structures of complete extracellular receptor assemblies mediated by IL-12 and IL-23 [J].
Bloch, Yehudi ;
Felix, Jan ;
Merceron, Romain ;
Provost, Mathias ;
Symakani, Royan Alipour ;
De Backer, Robin ;
Lambert, Elisabeth ;
Mehdipour, Ahmad R. ;
Savvides, Savvas N. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2024, 31 (04) :591-597
[5]  
Boje AS., 2024, MAbs, V16, P315
[6]   Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer [J].
Chanier, Timothee ;
Chames, Patrick .
ANTIBODIES, 2019, 8 (01)
[7]   Novel strategies exploiting interleukin-12 in cancer immunotherapy [J].
Cirella, Assunta ;
Luri-Rey, Carlos ;
Trani, Claudia Augusta Di ;
Teijeira, Alvaro ;
Olivera, Irene ;
Bolanos, Elixabet ;
Castanon, Eduardo ;
Palencia, Belen ;
Brocco, Davide ;
Fernandez-Sendin, Myriam ;
Aranda, Fernando ;
Berraondo, Pedro ;
Melero, Ignacio .
PHARMACOLOGY & THERAPEUTICS, 2022, 239
[8]  
Claus C., 2023, MAbs, V15, P167
[9]   The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses [J].
Crawford, Alison ;
Wherry, E. John .
CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (02) :179-186
[10]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398